Positive effects of coffee on liver fibrosis in patients with chronic hepatitis B
Clinical Nutrition — Barré T, Fontaine H, Ramier C, et al. | January 25, 2022
i>NOTE, original article title: Elevated coffee consumption is associated with a lower risk of elevated liver fibrosis biomarkers in patients treated for chronic hepatitis B (ANRS CO22 Hepather cohort)
Despite recent therapeutic advances, high risk of liver fibrosis, cirrhosis and liver cancer has been observed among patients chronically infected with hepatitis B virus (HBV). Researchers aimed at determining the socio-demographic and modifiable risk factors for significant fibrosis in chronic hepatitis B virus (HBV) patients by using cross-sectional data from the ANRS CO22 Hepather cohort.
A total of 2,065 untreated and 1,727 treated chronic HBV patients formed the study population.
As assessed by three non-invasive markers in treated chronic HBV patients, there appeared a consistent association of increased coffee consumption with a lower risk of significant liver fibrosis.
In real-world situations, immediate use of this result can be made, as patients at risk of advanced liver disease may benefit from increasing coffee consumption.
Read the full article on Clinical Nutrition